PALVELLA THERAPEUTICS, INC. - 05 Feb 2025 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
President and CEO, Director
Signature
By: /s/ Kathleen A. McGowan For: Wes Kaupinen
Issuer symbol
PVLA
Transactions as of
05 Feb 2025
Net transactions value
$0
Form type
4
Filing time
07 Feb 2025, 16:29:59 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Non-Qualified Stock Option (right to buy) Award $0 +243,831 $0.000000 243,831 05 Feb 2025 Common Stock 243,831 $14.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in equal monthly tranches over 48 months